Prilosec To Remain Rx Pending OTC Label Revisions, Patient Study – Cmte.
Executive Summary
AstraZeneca/Procter & Gamble's Prilosec should remain a prescription-only medication pending revisions to the proposed OTC label, a joint FDA advisory committee suggested June 21